Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TRxADE HEALTH, Inc. - Common Stock (NQ: MEDS )

7.590 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about TRxADE HEALTH, Inc. - Common Stock

< Previous 1 2 3 4 Next >
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q3 Financial Numbers, Corporate Highlights
Via Investor Brand Network
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
From Trxade Health, Inc.
Via GlobeNewswire
InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Bonum Health(TM) to Work with Insurance Brokers to Offer Telemedicine Services for SMB Employer Groups
Via Investor Brand Network
TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results
Via ACCESSWIRE
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Call to Discuss Upcoming 3Q Financial Results
Via Investor Brand Network
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups
From Trxade Health, Inc.
Via GlobeNewswire
TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m. Eastern Time
Via ACCESSWIRE
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Enters into $1.8M Registered Direct Offering
Via Investor Brand Network
TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Board Appointment of Leading Pharmaceutical Industry Expert
Via Investor Brand Network
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
From Trxade Health, Inc.
Via GlobeNewswire
TRxADE Health (NASDAQ: MEDS) Subsidiary, Bonum Health Enters into Telehealth Services Deal with Wakefern Food Corp.
TRxADE Health, Inc. (NASDAQ: MEDS) is engaged as a health services IT company, which is focused on digitalizing the entire 
Via Spotlight Growth
Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Launches TRxADE Prime Plus to Meet Customers’ Needs of On-Demand Inventory
Via Investor Brand Network
Topics Supply Chain
Exposures Supply Chain
TRxADE HEALTH Announces Termination of Public Offering of Common Stock
Via ACCESSWIRE
TRxADE HEALTH Announces Proposed Public Offering of Common Stock
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Strategic Board Appointment of Leading Pharmaceutical Industry Expert
Via Investor Brand Network
TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr. Jeff Newell to its Advisory Board
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q2 Financial Report Showing Revenue Growth
Via Investor Brand Network
TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform 
From TRxADE HEALTH, Inc.
Via AccessWire
InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Integra Pharma Partners with Pharmaceutical Co. to Help Network Members Succeed
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Upcoming Earnings Call
Via Investor Brand Network
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC
TAMPA, FL / ACCESSWIRE / July 12, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Integra... 
From TRxADE HEALTH, Inc.
Via AccessWire
Topics Economy
Exposures Supply Chain
TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m. Eastern Time
TAMPA, FL / ACCESSWIRE / July 11, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the... 
From TRxADE HEALTH, Inc.
Via AccessWire
InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Bonum Health Unveils Televeterinary Services
Via Investor Brand Network
Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services
TAMPA, FL / ACCESSWIRE / May 19, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare... 
From TRxADE HEALTH, Inc.
Via AccessWire
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Q1 2022 Financial Numbers, Operational Highlights
Via Investor Brand Network
TRxADE HEALTH Reports First Quarter Revenue Growth of 6% and Q1 2022 Financial Results
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / May 9, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health... 
From TRxADE HEALTH, Inc.
Via AccessWire
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Plans to Release Q1 2022 Financial Numbers
Via Investor Brand Network
TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m. Eastern Time
TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the... 
From TRxADE HEALTH, Inc.
Via AccessWire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.